BROOKS LABORATORIES
|
The Current P/E Ratio of BROOKS LABORATORIES is 490.21.
Share Price | ₹94.3 | Mar 27,2024 |
Market Cap | ₹247.1 Cr | |
Earnings-TTM | ₹0.5 Cr | TTM-Consolidated Results |
Price/Earnings | 490.21x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of BROOKS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹247.1 Cr] as on Mar 27,2024
(/) Earnings [ ₹0.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 490.21x ]
Thus, for BROOKS LABORATORIES , the investors are currently willing to pay 490.21 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BROOKS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BROOKS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of BROOKS LABORATORIES
PE Ratio Performance Analysis for BROOKS LABORATORIES
- BROOKS LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2021 averaged 0.00x.
- BROOKS LABORATORIES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, BROOKS LABORATORIES 's p/e ratio peaked in Mar2023 at 0x.
- BROOKS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does BROOKS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
BROOKS LABORATORIES | 0.50 | 490.21 | 247.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 42.88 | 385,837.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 64.59 | 89,323.5 |
CIPLA LTD | 3,744.03 | 31.62 | 118,376.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.37 | 100,885.0 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 58.09 | 86,779.1 |
ABBOTT INDIA LTD | 1,145.58 | 49.62 | 56,838.6 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 34.05 | 100,583.0 |
ALKEM LABORATORIES LTD | 1,574.66 | 37.96 | 59,770.5 |
LUPIN LTD | 1,809.74 | 40.24 | 72,826.6 |
BIOCON LTD | 1,611.00 | 19.12 | 30,807.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BROOKS LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.12x |
Max industry PE | 490.21x |
Median industry PE | 40.24x |
Average industry PE | 80.70x |
You may also like the below Video Courses